Piramal Pharma Limited (PPLPHARMA.NS)
INR 260.5
(-1.59%)
INR 260.5
(-1.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 47.1 Billion INR | -16.44% |
| 2022 | 56.37 Billion INR | 407.21% |
| 2021 | 11.11 Billion INR | 537.77% |
| 2020 | 1.74 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 46.43 Billion INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 47.1 Billion INR | -16.44% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 47.1 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 45.34 Billion INR | 0.0% |
| 2022 Q2 | 50.16 Billion INR | 0.0% |
| 2022 FY | 56.37 Billion INR | 407.21% |
| 2022 Q4 | 56.37 Billion INR | 7.44% |
| 2022 Q3 | 52.46 Billion INR | 4.59% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 11.11 Billion INR | 0.0% |
| 2021 FY | 11.11 Billion INR | 537.77% |
| 2020 FY | 1.74 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Biocon Limited | 162.76 Billion INR | 71.062% |
| Blue Jet Healthcare Limited | 16.12 Million INR | -291912.417% |
| Concord Biotech Limited | 97.37 Million INR | -48270.851% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | -103.674% |
| Jubilant Ingrevia Limited | 7.4 Billion INR | -536.293% |
| Lyka Labs Limited | 586.5 Million INR | -7930.95% |
| Panacea Biotec Limited | 209.9 Million INR | -22340.019% |
| SMS Lifesciences India Limited | 1 Billion INR | -4576.313% |
| Supriya Lifescience Limited | 54.88 Million INR | -85726.531% |
| Syngene International Limited | 5.55 Billion INR | -748.372% |
| TAKE Solutions Limited | 370.85 Million INR | -12600.984% |
| Zota Health Care Limited | 952.84 Million INR | -4843.254% |